First Affiliated Hospital Of Zhejiang University
Clinical trials sponsored by First Affiliated Hospital Of Zhejiang University, explained in plain language.
-
Tiny mesh tubes tested to seal off dangerous brain bulges
Disease control Recruiting nowThis study is testing a medical device called a flow-diverting stent to treat brain aneurysms, which are weak, bulging spots in a brain artery. Researchers will implant these tiny mesh tubes in 164 patients to redirect blood flow away from the aneurysm, aiming to seal it off. The…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
New Two-Drug attack tested to shrink breast tumors before surgery
Disease control Recruiting nowThis study is testing whether a combination of two drugs, trastuzumab rezetecan and toripalimab, can shrink tumors before surgery in people with a specific type of breast cancer (HR-positive, HER2-low). The main goal is to see if the treatment completely eliminates cancer cells i…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug added to transplant could stop blood Cancer's return
Disease control Recruiting nowThis study is testing if adding a drug called venetoclax to the standard pre-transplant chemotherapy improves outcomes for people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). About 138 patients aged 12-60 will be randomly assigned to receive eit…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for elderly blood cancer patients: major trial tests drug to make transplants more effective
Disease control Recruiting nowThis study is for people over 50 with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are getting a stem cell transplant. It compares two different drug combinations used to prepare the body for the transplant. The goal is to see if adding a drug called venetoc…
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo aims to shrink tumors and spare rectums
Disease control Recruiting nowThis study is testing a new treatment approach for people with a common type of advanced rectal cancer. It combines a short course of radiation, standard chemotherapy, and two new immunotherapy drugs to try to shrink tumors before surgery. The main goal is to see if this combinat…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Three-Pronged attack on aggressive breast cancer tested in new trial
Disease control Recruiting nowThis study is testing a three-drug combination given before surgery for triple-negative breast cancer (TNBC). The goal is to see if adding two newer drugs (sintilimab and bevacizumab) to standard chemotherapy can more effectively shrink or eliminate the tumor. Researchers will me…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New immune cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage study is testing the safety and initial effectiveness of a new CAR-T cell therapy called A-CAR028 for adults with acute myeloid leukemia (AML) that has returned or not responded to other treatments. The study will enroll up to 20 participants to determine safe do…
Phase: PHASE1 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New combo therapy aims to keep clogged veins open
Disease control Recruiting nowThis study is testing whether a combination of two blood-thinning medications can help keep a vein open after a stent is placed. It's for patients who have had a serious leg blood clot and a narrowed iliac vein that required a stent. Researchers want to see if this drug combinati…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New shot aims to speed blood recovery after cancer transplant
Disease control Recruiting nowThis study is testing if a weekly injection called Romiplostim N01 can help platelets recover faster after a stem cell transplant for blood cancers like leukemia. About 130 patients will be randomly assigned to receive either the new drug or standard care, and researchers will tr…
Phase: PHASE1 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug duo aims to tame deadly transplant complication
Disease control Recruiting nowThis study is for patients who develop a severe, life-threatening immune reaction (GVHD) after a stem cell transplant that doesn't respond to standard steroid treatment. It will test if adding a drug called etanercept to the current standard drug, ruxolitinib, works better than r…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New combo attack on aggressive breast cancer before surgery
Disease control Recruiting nowThis study is testing whether adding an immunotherapy drug called toripalimab to standard chemotherapy before surgery can be more effective for treating triple-negative breast cancer. It will involve about 35 women with early-stage disease to see if this combination can completel…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New Two-Pronged attack on blood cancer shows promise
Disease control Recruiting nowThis study is testing whether adding a newer drug called orelabrutinib to standard treatments works better for people newly diagnosed with marginal zone lymphoma, a type of blood cancer. It has two groups: one for younger, fitter patients and one for older patients or those less …
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for stem cell transplant patients battling dangerous complication
Disease control Recruiting nowThis study is testing a new drug called gecacitinib, combined with standard steroid treatment, for patients who develop a severe immune reaction called acute graft-versus-host disease after a stem cell transplant. The trial aims to find the safest and most effective dose and see …
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for older leukemia patients who Can't handle harsh chemo
Disease control Recruiting nowThis study is testing whether alternating two different drug combinations can better control acute myeloid leukemia (AML) in older adults or those with other health problems who cannot tolerate standard intensive chemotherapy. The treatment involves four cycles of alternating dru…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope to stop dangerous bleeding in transplant patients
Disease control Recruiting nowThis study is testing if a drug called etamsylate can prevent serious bleeding in patients who have low platelet counts after a stem cell transplant. About 404 adult patients will be randomly assigned to receive either etamsylate or a placebo (inactive substance) to see which is …
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists test new drug combo to fight blood cancer, hoping to spare patients from transplants
Disease control Recruiting nowThis study is testing a new treatment plan for adults with a specific genetic type of acute myeloid leukemia (AML). The goal is to see if a combination of targeted drugs and chemotherapy can control the cancer so well that a risky stem cell transplant might be avoided. Researcher…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope for tough blood cancers: experimental combo targets resistant leukemia
Disease control Recruiting nowThis study is testing whether a new three-drug combination can help control acute myeloid leukemia (AML) that has returned or hasn't responded to previous treatments. The trial will enroll 72 adults with relapsed or refractory AML to receive the drug combination and closely monit…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
New Triple-Threat treatment tested for advanced rectal cancer
Disease control Recruiting nowThis study is testing a new combination treatment for people with rectal cancer that has spread to a few other places in the body. The goal is to see if a short course of radiation, followed by chemotherapy and an immunotherapy drug, can better control the cancer and reduce the c…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
Could a simple scan replace painful biopsies for this blood disease?
Diagnosis Recruiting nowThis study is testing if a new type of imaging scan (called 18F-FAPI PET/MRI) can be used to diagnose and monitor myelofibrosis, a serious bone marrow disease. Researchers want to see if this scan is as good as or better than the current painful bone marrow biopsy, which cannot b…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Apr 01, 2026 21:41 UTC
-
New scan could spot prostate cancer more clearly
Diagnosis Recruiting nowThis study is testing if a new type of MRI scan can better detect prostate cancer. The scan looks at the size and density of cells inside the prostate, which may give doctors a clearer picture than standard MRI. About 2,000 men with suspected prostate cancer will get both the new…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Mar 27, 2026 12:37 UTC
-
Paddling toward recovery: dragon boats tested against home workouts for breast cancer patients
Symptom relief Recruiting nowThis study compares two exercise programs to help women recover after breast cancer surgery. Researchers want to see if 12 weeks of supervised dragon boat racing with a coach works better than following exercise videos at home alone. They will measure changes in body composition,…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
New sedative aims to reduce breathing risks during lung scans
Symptom relief Recruiting nowThis study is testing whether a new sedative drug called remimazolam can make bronchoscopy procedures safer for high-risk patients. Bronchoscopy involves inserting a camera into the lungs and often requires sedation, but current sedatives can sometimes cause breathing problems. R…
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Breathing breakthrough: new tube design aims to prevent oxygen drops during lung procedures
Symptom relief Recruiting nowThis study is testing a modified oxygen delivery method for patients undergoing sedated lung exams (bronchoscopy). Researchers are using a thinner breathing tube inserted through the nose to see if it provides better oxygen flow and reduces the risk of low oxygen levels during th…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC
-
Could a simple blood test track Alzheimer's treatment?
Knowledge-focused Recruiting nowThis study aims to see if specific blood tests can accurately track how well the Alzheimer's drug lecanemab is working. Researchers will observe 400 patients in China with early Alzheimer's who are already taking lecanemab. They will collect blood samples and brain scans over 18 …
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:41 UTC
-
Scientists search for hidden signs of consciousness in Brain-Injured patients
Knowledge-focused Recruiting nowThis study aims to learn more about patients with prolonged disorders of consciousness, such as those in a vegetative or minimally conscious state after a severe brain injury. Researchers will monitor tiny, subtle movements in response to emotional stimuli, along with brain scans…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:54 UTC
-
Surgery breathing tube test: which one works better?
Knowledge-focused Recruiting nowThis study is comparing a new design of breathing tube (called a GMA laryngeal mask) with the standard type used during surgery under general anesthesia. Researchers want to see which tube is easier for doctors to place correctly, provides a better seal, and causes fewer side eff…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:53 UTC
-
Researchers watch faces for clues to unlock consciousness mysteries
Knowledge-focused Recruiting nowThis study aims to understand if tiny, involuntary facial expressions (micro-expressions) can help doctors better assess consciousness levels in patients with severe brain injuries. Researchers will show emotional videos and sounds to 200 participants (150 patients and 50 healthy…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated Mar 03, 2026 14:07 UTC